| Closed |
SWOG-7315/16 |
Remission Induction for Adult Acute Leukemia with Ten-day OAP Remission Maintenance with OAP vs OAP plus BCG |
7/6/1973 |
1/1/1977 |
|
|
Published
|
| Closed |
SWOG-7204/7205 |
Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance |
4/17/1972 |
9/10/1974 |
|
|
Published
|
| Closed |
SWOG-781 |
Radiotherapy - Chemotherapy (MOPP) for Stages I and II, A and B Hodgkin's |
2/14/1972 |
8/8/1978 |
|
|
Published
|
| Closed |
SWOG-780 |
Combination Cyclophosphamide, Vincristine, Prednisone and Bleomycin for Non-Hodgkin's Lymphoma |
11/4/1971 |
2/8/1973 |
|
|
|
| Closed |
SWOG-774/775 |
Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4) |
7/20/1971 |
8/23/1974 |
|
|
Published
|
| Closed |
SWOG-160 |
Combined Radiotherapy and Chemotherapy for Stage II B, Stage III A and Stage III B Hodgkin's Disease |
3/18/1971 |
2/21/1975 |
|
|
|
| Closed |
SWOG-440 |
Bleomycin for Solid Tumors and Lymphomas |
12/11/1970 |
7/1/1971 |
|
|
Published
|
| Closed |
SWOG-438 |
Combined 5-Fluorouracil (NSC-19893) and Hydrazine-1- Acetyl-2-Picolinoyl (NSC-68626) Therapy in the Treatment of Adenocarcinoma of the Stomach and Colon and Carcinoid |
6/9/1970 |
6/15/1971 |
91% |
|
|
| Closed |
SWOG-437 |
NSC-409962 ... 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Phase II study ... Advanced Breast Cancer |
1/19/1970 |
|
53% |
|
|
| Closed |
SWOG-772/773 |
Hodgkin's Disease: Remission Consolidation with Actinomycin D, Vinblastine, and Methotrexate (MOPP#3) |
10/8/1969 |
11/9/1971 |
|
|
|
| Closed |
SWOG-229 |
Study of Dibromomannitol in Chronic Granulocytic Leukemia |
8/6/1969 |
|
1% |
|
|
| Closed |
SWOG-434 |
Imidazole Carboxamide Dimethyl Triazene (NSC-45388) in Patients with Solid Tumors (Excluding Melanomas, Lymphomas, and Breast Cancer) |
5/20/1969 |
6/24/1970 |
58% |
|
|
| Closed |
SWOG-431 |
Evaluation of Bis-Chlorethyl-nitrosourea (BCNU) in Multiple Myeloma |
4/16/1969 |
|
9% |
|
|
| Closed |
SWOG-227 |
Protocol for Phase II Trial of Actinomycin D & Vincristine in Lung Cancer |
8/6/1968 |
8/21/1969 |
0% |
|
|
| Closed |
SWOG-717 |
Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults |
7/29/1968 |
|
4% |
|
|
| Closed |
SWOG-756/759 |
Combination Chemotherapy in Advanced Hodgkin's Disease: Induction and Maintenance of Remission |
9/29/1967 |
9/1/1973 |
|
|
|
| Closed |
SWOG-703 |
Combination for Cyclophosphamide (NSC-26271), Vincristine (NSC-67574) and 5-Fluorouracil (NSC-19893) in the Treatment of Advanced Breast Cancer |
7/21/1967 |
|
93% |
|
|
| Closed |
SWOG-226 |
Phase II Protocol for Porfiromycin Solid Tumors |
7/12/1967 |
|
100% |
|
|
| Closed |
SWOG-427 |
Cytosine Arabinoside (NSC-63878) in Acute Leukemia in Adults |
7/1/1967 |
6/9/1969 |
2% |
|
|
| Closed |
SWOG-8264 |
Combination Chemotherapy with m-AMSA, Cis-Platinum and MGBG for Refractory Lymphoma |
8/11/1962 |
3/16/1984 |
|
|
Published
|
